{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:38:47Z","timestamp":1789162727389,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003969","name":"Ministry of Health and Medical Education","doi-asserted-by":"publisher","award":["700\/107"],"award-info":[{"award-number":["700\/107"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003969","name":"Ministry of Health and Medical Education","doi-asserted-by":"publisher","award":["26424"],"award-info":[{"award-number":["26424"]}],"id":[{"id":"10.13039\/501100003969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.sapharm.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:42:48Z","timestamp":1722591768000},"page":"1038-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-3010","authenticated-orcid":false,"given":"Pooria","family":"Zare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-8493","authenticated-orcid":false,"given":"Bita","family":"Mesgarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-9187","authenticated-orcid":false,"given":"Alireza","family":"Kamalipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Abdipour-Mehrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham-Sadat","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Ghamar-Shooshtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-1539","authenticated-orcid":false,"given":"Seyed Ali","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-3504","authenticated-orcid":false,"given":"Hamed","family":"Bazrafshan Drissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-8894","authenticated-orcid":false,"given":"Hossein","family":"Molavi Vardanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.07.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2024.07.006_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"European geriatric medicine"},{"key":"10.1016\/j.sapharm.2024.07.006_bib3","doi-asserted-by":"crossref","DOI":"10.34172\/aim.2021.94","article-title":"Prevalence, pattern, and correlates of polypharmacy among Iranian type II diabetic patients: results from pars cohort study","volume":"24","author":"Azadi","year":"2021","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.sapharm.2024.07.006_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.sapharm.2024.07.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40359-022-00716-9","article-title":"The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study","volume":"10","author":"Ghaed-Sharaf","year":"2022","journal-title":"BMC psychology"},{"key":"10.1016\/j.sapharm.2024.07.006_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pds.4941","article-title":"Polypharmacy in a semirural community in Chile: results from maule cohort","volume":"29","author":"Oyarz\u00fan\u2010Gonz\u00e1lez","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2024.07.006_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b7 1 million participants","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.sapharm.2024.07.006_bib10","first-page":"82","article-title":"Prevalence of medication adherence in patients with hypertension in Iran: a systematic review and meta-analysis of studies published in 2000-2018","volume":"15","author":"Jafari Oori","year":"2019","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.sapharm.2024.07.006_bib11","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018020","article-title":"Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran","volume":"40","author":"Eghbali","year":"2018","journal-title":"Epidemiology and health"},{"key":"10.1016\/j.sapharm.2024.07.006_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmrp.2020.03.008","article-title":"Antihypertensive drug adherence and its association with blood pressure control status","volume":"10","author":"Seify","year":"2020","journal-title":"Current Medicine Research and Practice"},{"key":"10.1016\/j.sapharm.2024.07.006_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.31254\/jsir.2014.3402","article-title":"Self- medication among Iranian Hypertensive patients in central Iran","volume":"3","author":"Sarahroodi","year":"2014","journal-title":"Journal of Scientific and Innovative Research"},{"key":"10.1016\/j.sapharm.2024.07.006_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pds.5418","article-title":"Population\u2010based prevalence of polypharmacy and patterns of medication use in southwestern Iran: a cross\u2010sectional study","volume":"31","author":"Taherifard","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2024.07.006_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jch.12624","article-title":"Polypharmacy in older adults with hypertension: a comprehensive review","volume":"18","author":"Mukete","year":"2016","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.sapharm.2024.07.006_bib16","article-title":"Cross-sectional observational study on association of polypharmacy with health-related quality of life in patients with hypertension","volume":"14","author":"Paramba","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.sapharm.2024.07.006_bib17","doi-asserted-by":"crossref","DOI":"10.1590\/0034-7167-2022-0785","article-title":"Polypharmacy, potentially inappropriate medications and associated factors among older adults with hypertension in primary care","volume":"76","author":"Sangaleti","year":"2023","journal-title":"Rev Bras Enferm"},{"key":"10.1016\/j.sapharm.2024.07.006_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2023.e02028","article-title":"Polypharmacy and its associated factors among patients with co-morbid hypertension and diabetes in a municipal hospital in Ghana","volume":"23","author":"Kwakye","year":"2024","journal-title":"Scientific African"},{"key":"10.1016\/j.sapharm.2024.07.006_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.34172\/ddj.2020.05","article-title":"Relationship between polypharmacy and medication adherence in the hypertensive elderly patients","volume":"9","author":"Shareinia","year":"2020","journal-title":"Disease and Diagnosis"},{"key":"10.1016\/j.sapharm.2024.07.006_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00038-016-0848-2","article-title":"Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results","volume":"62","author":"Gandomkar","year":"2017","journal-title":"Int J Publ Health"},{"key":"10.1016\/j.sapharm.2024.07.006_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/aje\/kwx314","article-title":"Prospective epidemiological research studies in Iran (the Persian Cohort Study): rationale, objectives, and design","volume":"187","author":"Poustchi","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib22","series-title":"WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment 2020","author":"Organization","year":"2019"},{"key":"10.1016\/j.sapharm.2024.07.006_bib23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.sapharm.2024.07.006_bib24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sapharm.2024.07.006_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/fmch-2019-000262","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"Chowdhury","year":"2020","journal-title":"Family Medicine and Community Health"},{"key":"10.1016\/j.sapharm.2024.07.006_bib26","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.sapharm.2024.07.006_bib27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.sapharm.2024.07.006_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.15171\/mejdd.2018.94","article-title":"Prevalence of chronic constipation and its associated factors in pars cohort study: a study of 9000 adults in Southern Iran","volume":"10","author":"Moezi","year":"2018","journal-title":"Middle East journal of digestive diseases"},{"key":"10.1016\/j.sapharm.2024.07.006_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/ajh\/hpab066","article-title":"Clinical correlates of early-onset hypertension","volume":"34","author":"Suvila","year":"2021","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.sapharm.2024.07.006_bib30","author":"Kluwer"},{"key":"10.1016\/j.sapharm.2024.07.006_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcvm.2020.00049","article-title":"Hypertension and drug adherence in the elderly","volume":"7","author":"Burnier","year":"2020","journal-title":"Frontiers in cardiovascular medicine"},{"key":"10.1016\/j.sapharm.2024.07.006_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"Khezrian","year":"2020","journal-title":"Therapeutic advances in drug safety"},{"key":"10.1016\/j.sapharm.2024.07.006_bib33","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-126922","article-title":"Prevalence and predicting risk factors of polypharmacy in azar cohort population","author":"Gharekhani","year":"2022","journal-title":"Iran J Pharm Res (IJPR)"},{"key":"10.1016\/j.sapharm.2024.07.006_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4842520","article-title":"The humanistic and economic burden associated with anxiety and depression among adults with comorbid diabetes and hypertension","volume":"2018","author":"Wallace","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.sapharm.2024.07.006_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00592-015-0790-4","article-title":"Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment","volume":"53","author":"Noale","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01275-x","article-title":"Low-density lipoprotein cholesterol lowering treatment: the current approach","volume":"19","author":"Crismaru","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.sapharm.2024.07.006_bib37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/medicina57121288","article-title":"Polypharmacy in the management of arterial hypertension\u2014friend or foe?","volume":"57","author":"Diaconu","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.sapharm.2024.07.006_bib38","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sapharm.2024.07.006_bib39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4070\/kcj.2016.46.5.672","article-title":"Prevalence of comorbidity among people with hypertension: the Korea National health and nutrition examination survey 2007-2013","volume":"46","author":"Noh","year":"2016","journal-title":"Korean circulation journal"},{"key":"10.1016\/j.sapharm.2024.07.006_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.maturitas.2018.03.013","article-title":"Hypertension in patients with type 2 diabetes mellitus: targets and management","volume":"112","author":"Pavlou","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.sapharm.2024.07.006_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/HYPERTENSIONAHA.111.00612","article-title":"Diabetes mellitus and vascular disease","volume":"61","author":"Sowers","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.sapharm.2024.07.006_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4276047","article-title":"Diseases linked to polypharmacy in elderly patients","author":"Vrettos","year":"2017","journal-title":"Current gerontology and geriatrics research"},{"key":"10.1016\/j.sapharm.2024.07.006_bib43","article-title":"Cardiometabolic diseases and active aging-polypharmacy in control","volume":"73","author":"Santos","year":"2020","journal-title":"Rev Bras Enferm"},{"key":"10.1016\/j.sapharm.2024.07.006_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0895-7061(97)00056-3","article-title":"The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly","volume":"10","author":"Monane","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.sapharm.2024.07.006_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-021-01131-y","article-title":"Drug interactions with antihypertensives","volume":"23","author":"Fravel","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.sapharm.2024.07.006_bib46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.redox.2016.08.001","article-title":"Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction","volume":"9","author":"Pinheiro","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0976-0105.134983","article-title":"A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital","volume":"5","author":"Patel","year":"2014","journal-title":"J Basic Clin Pharm"},{"key":"10.1016\/j.sapharm.2024.07.006_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.1351","article-title":"Hospitalisations and emergency department visits due to drug\u2013drug interactions: a literature review","volume":"16","author":"Becker","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2024.07.006_bib50","article-title":"Potential drug-drug interactions among medications prescribed to hypertensive patients","volume":"8","author":"Kothari","year":"2014","journal-title":"J Clin Diagn Res: J Clin Diagn Res"},{"key":"10.1016\/j.sapharm.2024.07.006_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5455\/2319-2003.ijbcp20130306","article-title":"Assessment of potential drug-drug interactions among outpatients receiving cardiovascular medications at Jimma University specialized hospital, South West Ethiopia","volume":"2","author":"Chelkeba","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2024.07.006_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/picr.PICR_145_16","article-title":"Study of drug\u2013drug interactions among the hypertensive patients in a tertiary care teaching hospital","volume":"9","author":"Subramanian","year":"2018","journal-title":"Perspectives in clinical research"},{"key":"10.1016\/j.sapharm.2024.07.006_bib53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2024.07.006_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/2042018816638050","article-title":"Clinically and pharmacologically relevant interactions of antidiabetic drugs","volume":"7","author":"May","year":"2016","journal-title":"Therapeutic advances in endocrinology and metabolism"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:12:26Z","timestamp":1726632746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1551741124002316"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.07.006","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}